降温火焰:使用非激素药物应对更年期的血管运动症状
Erin Carson1, Veronica Vernon2, Lauren Cunningham3
1University of Illinois Chicago College of Pharmacy, Chicago, IL, and UWHealth Northern Illinois, Rockford, IL, USA.
新的非激素处方疗法,包括fezolinetant,为管理更年期血管运动症状提供了替代方案. 费索利内坦显示显著的症状减轻,与激素疗法相比,解决更年期治疗的不足.
科学领域:
- 更年期管理管理
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
背景情况:
- 更年期的血管运动症状显著影响生活质量.
- 激素治疗是黄金标准,但由于各种担忧而未得到充分利用.
- 非激素处方疗法为更年期症状管理提供了替代治疗选择.
研究的目的:
- 更新药剂师关于非荷尔蒙处方治疗更年期血管运动症状的证据.
- 审查新的药物的疗效,如fezolinetant与既有的非激素选择一起.
- 突出药剂师在解决更年期症状治疗缺口方面的作用.
主要方法:
- 对处方非激素疗法的当前证据的审查.
- 对fezolinetant和其他药物的临床试验数据的摘要.
- 对治疗效率和比较有效性的分析.
主要成果:
- 非激素的选择包括SSRI (帕罗丁),SNRIs, gabapentin, 普雷加巴林, oxybutynin 和 fezolinetant.
- 大多数非激素疗法提供轻度到中度的症状改善.
- 费索利尼坦 (Fezolinetant) 显著降低了血管运动症状的频率,与激素治疗相比.
结论:
- 非激素疗法对于无法或不愿意使用激素治疗的患者至关重要.
- 费索利内坦特是一种有前途的选择,其疗效可能与激素治疗相匹配.
- 需要进一步研究fezolinetant的可负担性和对头对头比较.
更多相关视频
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
相关概念视频
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Antihypertensive Drugs: Vasodilators
Antidepressant Drugs: MAOIs and Other Agents
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
